 |
|
|
|
|
Novacea's management team has significant experience and expertise in licensing, drug development and commercialization spanning the entire development process (pre-IND through post-marketing). Members of this team average over 20 years of experience, including:
- Creating and leading drug development organizations
- Commercializing novel therapeutics
- Identifying and evaluating in-licensing opportunities
John P. Walker
Interim Chief Executive Officer and Chairman of the Board
Mr. Walker is an experienced leader in the biotechnology industry and currently serves as chairman of the Board of Directors for Novacea and for Renovis, Inc. He also serves on the Board of Directors for Affymax, Inc. and Geron Corporation. During his 35-year career, Mr. Walkerhas served as Chairman, CEO or interim CEO of a number of biotechnology and pharmaceutical companies, including KAI Pharmaceuticals and of Guava Technologies. From 1993 to 2001, he was Chairman, CEO, and a director of AXYS Pharmaceuticals, Inc. and its predecessor company Arris Pharmaceutical Corporation. Prior to Arris, Mr. Walker was Chairman and CEO of Vitaphore Corporation, a biomaterials company that was sold to Union Carbide Chemical and Plastics Company, Inc. Mr. Walker began his career with American Hospital Supply Corporation, where he held a variety of general management, sales, and operational positions and served as President of American Medical Systems and The Hospital Company.
|
John G. Curd, M.D.
President and Chief Medical Officer
John G. Curd, M.D. is our third employee and has served as
our President and Chief Medical Officer since
December 2001. From May 2001 to December 2001, Dr. Curd served as Senior Vice
President of Development
and Interim President for Vaccines at Maxygen, Inc., a biotechnology company.
From June 1999 to May 2001,
Dr. Curd served as Executive Vice President at VaxGen, Inc., a vaccine company.
From December 1991 to June
1999, Dr. Curd served in various positions, including Vice President of Clinical
Development at Genentech.
While at Genentech, he directed the clinical development of Herceptin®, Rituxan®,
Xolair™ and Raptiva™. From 1978 to 1991, Dr. Curd served in various positions,
including President of the Medical Staff at Scripps Clinical and Research Foundation,
La Jolla, California. Dr. Curd holds a B.S. in chemistry from Princeton University
and an M.D. from Harvard Medical School.
|
Amar Singh
Chief Commercialization Officer
Amar Singh has served as our Chief Commercialization Officer
since February 2006. From August 2003 to
January 2006, Mr. Singh served as Vice President of Marketing and Sales at Abraxis
Oncology, a proprietary
division of American Pharmaceutical Partners, Inc. Prior to joining American
Pharmaceutical Partners, Mr.
Singh served in multiple capacities at Roche Laboratories, a Division of Hoffmann
La Roche, where he held
positions in Market Research, Licensing and Business Development, New Product
Planning and Marketing.
From 2000 to 2003, he was Executive Director for Oncology Marketing and subsequently
for New Product
planning for the Specialty Care business. Mr. Singh holds a B.A. from the University
of North Carolina Chapel
Hill and an M.B.A. from New York University.
|
Edward C. Albini
Vice President and Chief Financial Officer
Edward C. Albini has served as our Vice President
and Chief Financial Officer since February 2004. From
April 1997 to February 2004, Mr. Albini served as Chief Financial Officer at
Lynx Therapeutics, Inc. (now
Solexa Inc.), a biotechnology company. From January 1983 to April 1997, he served
in various senior financial
management positions at Genentech, including Director of Financial Planning and
Analysis and Assistant
Controller. He has also served as an auditor for Peat, Marwick, Mitchell & Co.,
now KPMG, LLP. Mr. Albini holds a B.S. in accounting from Santa Clara University
and an M.B.A. from the Haas School of Business at the University of California
at Berkeley. He is a certified public accountant. |
Ivy Ang
Vice President, Human Resources
Ivy Ang has served as our Vice President of Human Resources
since August 2005. From April 1998 to
August 2005, Ms. Ang worked as a consultant to numerous private companies. From
February 1996 to April
1998, Ms. Ang served as Vice President of Human Resources Worldwide for Madge
Networks. From March
1992 to February 1996, Ms. Ang served as an Associate Director at Genentech.
Ms. Ang holds a B.A. from the
College of Notre Dame
.
|
| |
|
|
 |
| Click here to read the biographies of members of Novacea's Board of Directors. |
|
 |
|
|
|
|
|
|
|
|
|
